Targeted drug therapy found effective in patients with common form of immune-mediated kidney disease

Links shared publicly online about this topic.

2,719
total visits

Targeted drug therapy found effective in patients with common form of immune-mediated kidney disease

The drug rituximab causes considerable kidney injury healing in patients with membranous nephropathy, a common form of kidney disease, according to a study appearing in the November 2008 issue of the Clinical Journal of the American Society Nephrology. The results suggest that this condition, previously destined to progress to kidney failure in 30-40 percent of cases, can actually be healed in some patients.

View full resource at eurekalert.org

Tags: Urinary System, Kidney Disease, Kidney Failure, Disease and Condition, Drug, Rituxan, MabThera, Nephrology